DBV Technologies SA header image

DBV Technologies SA

DBV

Equity

ISIN FR0010417345 / Valor 2857349

Euronext - Euronext Paris (2026-08-28)

EUR 2.37-4.20%

DBV Technologies SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

DBV Technologies SA is a clinical-stage biopharmaceutical company based in France that develops allergy immunotherapies using a proprietary epicutaneous delivery platform (EPIT) designed to administer allergens via a skin patch to induce desensitization while avoiding systemic exposure. Its most advanced program is Viaskin Peanut, a patch intended to treat peanut allergy, and the company has extended the EPIT approach to other food and environmental allergens in its pipeline. DBV focuses on clinical development, regulatory filings and potential commercialization of these immunotherapies, and is publicly listed in Europe and the United States.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

50.3%1Y

-18.4%3Y

-73.6%5Y

Performance

69.4%1Y

74.7%3Y

73.7%5Y

Volatility

814 M

Market cap (USD)

1,224,408

Daily traded volume (Shares)

/

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

bioMerieux SA

bioMerieux SA Valor: 38147803

Annual Return

-50%0%+50%

Risk level

110

-0.33%EUR 75.25

Heidelberg Pharma AG

Heidelberg Pharma AG Valor: 24937540

Annual Return

-50%0%+50%

Risk level

110

4.80%EUR 2.62

agilon health inc

agilon health inc Valor: 110653729

Annual Return

-50%0%+50%

Risk level

110

-1.74%USD 92.54

Ipsen

Ipsen Valor: 2348805

Annual Return

-50%0%+50%

Risk level

110

-3.61%EUR 163.10

Strides Pharma Science Ltd

Strides Pharma Science Ltd Valor: 1071169

Annual Return

-50%0%+50%

Risk level

110

3.88%INR 1,020.55

Laurus Labs Ltd.

Laurus Labs Ltd. Valor: 56464789

Annual Return

-50%0%+50%

Risk level

110

0.80%INR 1,935.30

Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited Valor: 136422285

Annual Return

-50%0%+50%

Risk level

110

-0.43%INR 1,871.25

Ambea AB

Ambea AB Valor: 36138415

Annual Return

-50%0%+50%

Risk level

110

0.75%SEK 175.00

Molina Healthcare Inc

Molina Healthcare Inc Valor: 1538184

Annual Return

-50%0%+50%

Risk level

110

0.63%USD 200.00

Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Inc Valor: 12015449

Annual Return

-50%0%+50%

Risk level

110

-1.42%USD 280.49

SIX

FactSet

Clearbit

Logos provided by Clearbit